About 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide
4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide (PubChem CID 70682194) has the molecular formula C38H46N6O3
and a molecular weight of 634.83 g/mol. Its IUPAC name is 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide.
Molecular Properties
| Compound Name | 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide |
| PubChem CID | 70682194 |
| Molecular Formula | C38H46N6O3 |
| Molecular Weight | 634.83 g/mol |
| Exact Mass | 634.36 |
| IUPAC Name | 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide |
| SMILES | O=C(N[C@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCC(N2CCCCC2)CC1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 |
| InChI | InChI=1S/C38H46N6O3/c45-36(42-23-17-31(18-24-42)41-21-7-2-8-22-41)34(27-28-13-15-30(16-14-28)29-9-3-1-4-10-29)40-37(46)43-25-19-32(20-26-43)44-35-12-6-5-11-33(35)39-38(44)47/h1,3-6,9-16,31-32,34H,2,7-8,17-27H2,(H,39,47)(H,40,46)/t34-/m1/s1 |
| InChIKey | XQQODFXEFSPXTA-UUWRZZSWSA-N |
| XLogP | 5.43 |
| TPSA | 93.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 634.83 |
| LogP ≤ 5 | 5.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Analyze 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide?
The IUPAC name of 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide (CID 70682194) is 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide.
What is the SMILES notation for 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide?
The canonical SMILES for 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide is O=C(N[C@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCC(N2CCCCC2)CC1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1.
What is the InChIKey of 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide?
The InChIKey is XQQODFXEFSPXTA-UUWRZZSWSA-N. The full InChI is InChI=1S/C38H46N6O3/c45-36(42-23-17-31(18-24-42)41-21-7-2-8-22-41)34(27-28-13-15-30(16-14-28)29-9-3-1-4-10-29)40-37(46)43-25-19-32(20-26-43)44-35-12-6-5-11-33(35)39-38(44)47/h1,3-6,9-16,31-32,34H,2,7-8,17-27H2,(H,39,47)(H,40,46)/t34-/m1/s1.
What are the key properties of 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide?
4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide has a molecular weight of 634.83 g/mol, XLogP of 5.43, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2-oxo-3H-benzimidazol-1-yl)-N-[(2R)-1-oxo-3-(4-phenylphenyl)-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide is sourced from PubChem (CID 70682194), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).